UK Immune Cell Therapy Biotech Founded with €40M Series A
Updated: Jun 7, 2019
Quell Therapeutics, a London-based biotech developing immune cell therapies to target transplant rejection and autoimmune and inflammatory diseases.
top of page
bottom of page